February 2024 Stock Gainers on News, Micro Caps Included
Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.
Data as of the trading session of , 20 of 20 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.
On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.
Whole board, unfiltered
100
Ranked gains
+1092.05%
Largest, HOLO
92.0%
Above baseline, day +5
8.5%
Median give-back, day +5
Filter and sort
100 ranked gains in February 2024
Skip the ranked rows and go to the month summaryEvery percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.
| Rank | Symbol | close to close | Session | Catalyst | Announcement | from the pre-news close |
|---|---|---|---|---|---|---|
| 1 | HOLO | +1092.05% |
against the close of 2024-02-06
session reconstructed
Session detail |
Other Announcement |
MicroCloud Hologram Planned to Join the Communications Industry Association
05:20 ET premarket |
Five sessions later the move was 27.5% bigger, at +1392.05%. Month end +543.05% on 2024-02-29 |
| 2 | BMR under $25M today More than one ranked move this month 2+ ranked moves | +371.56% |
against the close of 2024-02-09
session reconstructed
Session detail |
Other Announcement |
Beamr and NVIDIA team up to accelerate adoption of the newest video standard - AV1
07:00 ET premarket |
Five sessions later the move was 31.3% bigger, at +487.68%. Month end +280.57% on 2024-02-29 |
| 3 | GRYP under $25M today Also on the opposite board this month on both boards | +354.62% |
against the close of 2024-02-08
session reconstructed
Session detail |
Crypto & Treasury |
Gryphon Digital Mining Debuts on Nasdaq
09:28 ET premarket |
85.8% of the move was gone five sessions later. Month end +107.80% on 2024-02-29 |
| 4 | VANI | +270.30% |
against the close of 2024-02-27
session reconstructed
Session detail |
Clinical Trial Results |
Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio
08:30 ET premarket |
56.0% of the move was gone five sessions later. Month end +317.82% on 2024-02-29 This month ended before the fifth session after the move. |
| 5 | JANX | +229.47% |
against the close of 2024-02-26
session reconstructed
Session detail |
Other Announcement |
Janux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors
16:05 ET after hours |
18.8% of the move was gone five sessions later. Month end +220.40% on 2024-02-29 This month ended before the fifth session after the move. |
| 6 | GXAI under $25M today | +177.18% |
against the close of 2024-02-15
session reconstructed
Session detail |
Other Announcement |
Gaxos Gaming to Launch AI Solution for Game Developers and Studios
08:30 ET premarket |
9.5% of the move was gone five sessions later. Month end +108.82% on 2024-02-29 |
| 7 | INBS under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | +146.89% |
against the close of 2024-02-01
session reconstructed
Session detail |
Earnings |
Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue Results
08:30 ET premarket |
Five sessions later the move was 23.0% bigger, at +180.71%. Month end +107.47% on 2024-02-29 |
| 8 | INBS under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | +134.90% |
against the close of 2024-02-08
session reconstructed
Session detail |
Earnings |
Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights
08:30 ET premarket |
60.4% of the move was gone five sessions later. Month end +73.61% on 2024-02-29 |
| 9 | SCTL | +132.61% |
against the close of 2024-02-28
session reconstructed
Session detail |
M&A / Acquisition |
Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
16:29 ET after hours |
1.6% of the move was gone five sessions later. Month end +132.61% on 2024-02-29 same session This month ended before the fifth session after the move. |
| 10 | VKTX | +121.02% |
against the close of 2024-02-26
session reconstructed
Session detail |
Clinical Trial Results |
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity
07:03 ET premarket |
Five sessions later the move was 6.1% bigger, at +128.43%. Month end +100.23% on 2024-02-29 This month ended before the fifth session after the move. |
| 11 | ENGN | +116.54% |
against the close of 2024-02-13
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
enGene Announces Oversubscribed $200 Million Private Placement Financing
06:50 ET premarket |
7.4% of the move was gone five sessions later. Month end +93.57% on 2024-02-29 |
| 12 | GLT | +106.25% |
against the close of 2024-02-06
session reconstructed
Session detail |
M&A / Acquisition |
Berry Global and Glatfelter Announce Plans for Tax-Free Spin-Off and Merger of Berry’s Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter, Creating a Global Specialty Materials Leader
07:00 ET premarket |
23.5% of the move was gone five sessions later. Month end +74.22% on 2024-02-29 |
| 13 | AKLI | +104.11% |
against the close of 2024-02-23
session reconstructed
Session detail |
Clinical Trial Results |
Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan
08:47 ET premarket |
48.7% of the move was gone five sessions later. Month end +73.01% on 2024-02-29 This month ended before the fifth session after the move. |
| 14 | NSTG Also on the opposite board this month on both boards | +97.93% |
against the close of 2024-02-08
session reconstructed
Session detail |
Other Announcement |
NanoString Announces Completion of Financing to Support Restructuring Process
06:30 ET premarket |
It gave back the whole move and closed 50.95% below the pre-news price. Month end +3.18% on 2024-02-29 |
| 15 | MNPR More than one ranked move this month 2+ ranked moves | +96.49% |
against the close of 2024-02-21
session reconstructed
Session detail |
Clinical Trial Results |
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
07:00 ET premarket |
52.7% of the move was gone five sessions later. Month end +45.61% on 2024-02-29 |
| 16 | GRRR | +96.36% |
against the close of 2024-02-02
session reconstructed
Session detail |
Earnings |
Gorilla Technology Group Reports Results Through Third Quarter 2023
08:00 ET premarket |
23.4% of the move was gone five sessions later. Month end +60.46% on 2024-02-29 |
| 17 | VTVT | +95.88% |
against the close of 2024-02-27
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund
08:00 ET premarket |
23.9% of the move was gone five sessions later. Month end +106.47% on 2024-02-29 This month ended before the fifth session after the move. |
| 18 | MNPR More than one ranked move this month 2+ ranked moves | +95.27% |
against the close of 2024-02-16
session reconstructed
Session detail |
Clinical Trial Results |
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
08:00 ET premarket |
Five sessions later the move was 165.7% bigger, at +253.18%. Month end +142.27% on 2024-02-29 |
| 19 | HTOO under $25M today | +90.00% |
against the close of 2024-02-15
session reconstructed
Session detail |
Other Announcement |
Fusion Fuel Receives Notification of IPCEI Approval from European Commission for 630 MW HEVO-Portugal Project
04:00 ET premarket |
34.3% of the move was gone five sessions later. Month end +30.83% on 2024-02-29 |
| 20 | FBLG under $25M today Also on the opposite board this month on both boards | +88.38% |
against the close of 2024-02-12
session reconstructed
Session detail |
Clinical Trial Results |
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
09:31 ET intraday |
23.5% of the move was gone five sessions later. Month end +76.49% on 2024-02-29 |
| 21 | ADIL under $25M today | +85.50% |
against the close of 2024-02-27
session reconstructed
Session detail |
Other Announcement |
Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
09:30 ET intraday |
Five sessions later the move was 68.3% bigger, at +143.90%. Month end +133.60% on 2024-02-29 This month ended before the fifth session after the move. |
| 22 | FDMT | +84.62% |
against the close of 2024-02-02
session reconstructed
Session detail |
Clinical Trial Results |
4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD
17:00 ET after hours |
30.0% of the move was gone five sessions later. Month end +60.21% on 2024-02-29 |
| 23 | PLCE Also on the opposite board this month release reads negative on both boards | +81.12% |
against the close of 2024-02-14
session reconstructed
Session detail |
Other Announcement Release reads negative, stock rose 81.12% |
The Children’s Place Provides Shareholder Update
06:30 ET premarket |
50.2% of the move was gone five sessions later. Month end +32.55% on 2024-02-29 |
| 24 | BOF | +80.06% |
against the close of 2024-02-09
session reconstructed
Session detail |
Other Announcement |
BranchOut Food Expands Relationship with Nation’s Largest Retailer, Valued at an estimated $7.6M Annually
08:00 ET premarket |
Five sessions later the move was 6.8% bigger, at +85.51%. Month end +56.83% on 2024-02-29 |
| 25 | EBS | +78.29% |
against the close of 2024-02-20
session reconstructed
Session detail |
Leadership Change |
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
07:00 ET premarket |
Five sessions later the move was 41.2% bigger, at +110.53%. Month end +112.50% on 2024-02-29 |
| 26 | ENVB under $25M today | +74.49% |
against the close of 2024-02-28
session reconstructed
Session detail |
Other Announcement |
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
07:00 ET premarket |
Five sessions later the move was 11.3% bigger, at +82.91%. Month end +74.49% on 2024-02-29 same session This month ended before the fifth session after the move. |
| 27 | TELO | +69.76% |
against the close of 2024-02-13
session reconstructed
Session detail |
Uplisting / Compliance |
Telomir Pharmaceuticals Announces Closing of Initial Public Offering
16:05 ET after hours |
61.2% of the move was gone five sessions later. Month end +29.39% on 2024-02-29 |
| 28 | AXTI | +69.30% |
against the close of 2024-02-22
session reconstructed
Session detail |
Earnings |
AXT, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
16:05 ET after hours |
Five sessions later the move was 25.9% bigger, at +87.28%. Month end +88.16% on 2024-02-29 This month ended before the fifth session after the move. |
| 29 | NRBO under $25M today | +67.28% |
against the close of 2024-01-31
session reconstructed
Session detail |
FDA & Regulatory |
NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity
08:01 ET premarket |
51.8% of the move was gone five sessions later. Month end +77.06% on 2024-02-29 |
| 30 | MSAI under $25M today | +65.57% |
against the close of 2024-02-14
session reconstructed
Session detail |
Other Announcement |
MultiSensor AI Unveils SmartIR 2.0 Software Platform
14:05 ET intraday |
65.5% of the move was gone five sessions later. Month end +25.00% on 2024-02-29 |
| 31 | SEED under $25M today | +64.34% |
against the close of 2024-02-20
session reconstructed
Session detail |
Other Announcement |
Origin Agritech Grows Revenue by 77% Year-Over-Year, Records Net Income of $8.7 Million
07:00 ET premarket |
65.5% of the move was gone five sessions later. Month end +22.60% on 2024-02-29 |
| 32 | MRVI | +63.60% |
against the close of 2024-02-22
session reconstructed
Session detail |
Earnings |
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
16:05 ET after hours |
23.7% of the move was gone five sessions later. Month end +51.27% on 2024-02-29 This month ended before the fifth session after the move. |
| 33 | COGT | +59.34% |
against the close of 2024-02-13
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
07:00 ET premarket |
Five sessions later the move was 7.7% bigger, at +63.92%. Month end +28.21% on 2024-02-29 |
| 34 | BZFD | +58.10% |
against the close of 2024-02-21
session reconstructed
Session detail |
M&A / Acquisition |
BuzzFeed, Inc. Announces Sale of Complex to NTWRK in All-Cash Deal
16:05 ET after hours |
2.0% of the move was gone five sessions later. Month end +56.91% on 2024-02-29 |
| 35 | FHTX | +55.45% |
against the close of 2024-02-07
session reconstructed
Session detail |
Other Announcement |
Foghorn Provides Pipeline Update on FHD-909 BRM Selective Inhibitor
07:00 ET premarket |
Five sessions later the move was 113.3% bigger, at +118.27%. Month end +147.76% on 2024-02-29 |
| 36 | ZENV under $25M today | +54.78% |
against the close of 2024-02-05
session reconstructed
Session detail |
Other Announcement |
Zenvia Announces Agreements to Address Funding Gap and Introduces EBITDA Guidance for 2024
09:15 ET premarket |
Five sessions later the move was 9.5% bigger, at +60.00%. Month end +78.26% on 2024-02-29 |
| 37 | KPRX under $25M today | +53.87% |
against the close of 2024-01-31
session reconstructed
Session detail |
Clinical Trial Results |
Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement to Develop and Commercialize KIO-301 for the Treatment of Inherited Retinal Diseases; Total Deal Value of up to $301 Million includes $16 Million Upfront, up to $285 Million in Clinical Development, Regulatory and Commercial Milestones, Plus Commercial Royalties
17:15 ET after hours |
61.6% of the move was gone five sessions later. Month end +21.47% on 2024-02-29 |
| 38 | SOGP | +53.74% |
against the close of 2024-02-20
session reconstructed
Session detail |
Other Announcement |
Sound Group Embraces Generative AI to Unveil New AI-Powered Applications
06:30 ET premarket |
52.4% of the move was gone five sessions later. Month end +25.22% on 2024-02-29 |
| 39 | BFRI under $25M today | +53.44% |
against the close of 2024-02-16
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules
08:05 ET premarket |
70.1% of the move was gone five sessions later. Month end +11.77% on 2024-02-29 |
| 40 | ROOT | +53.29% |
against the close of 2024-02-21
session reconstructed
Session detail |
Earnings |
Root, Inc. Announces 2023 Fourth Quarter and Full Year Results
16:15 ET after hours |
Five sessions later the move was 407.3% bigger, at +270.36%. Month end +270.36% on 2024-02-29 |
| 41 | BAND | +51.77% |
against the close of 2024-02-27
session reconstructed
Session detail |
Earnings |
Bandwidth Announces Fourth Quarter and Full Year 2023 Financial Results, Exceeding Revenue and Profitability Guidance
07:00 ET premarket |
Five sessions later the move was 16.2% bigger, at +60.16%. Month end +69.05% on 2024-02-29 This month ended before the fifth session after the move. |
| 42 | CNVS Also on the opposite board this month on both boards | +51.61% |
against the close of 2024-02-13
session reconstructed
Session detail |
Contract / Partnership |
Cineverse Partners with Google Cloud to Launch a Conversational AI-Powered Search & Discovery Tool for Film and Television Content
09:00 ET premarket |
It gave back the whole move and closed 9.68% below the pre-news price. Month end -14.84% on 2024-02-29 |
| 43 | ARM | +47.89% |
against the close of 2024-02-07
session reconstructed
Session detail |
Earnings |
Arm Holdings plc Reports Results for the Third Quarter of the Financial Year Ending 2024
16:02 ET after hours |
Five sessions later the move was 53.7% bigger, at +73.59%. Month end +83.15% on 2024-02-29 |
| 44 | CISO under $25M today | +47.00% |
against the close of 2024-02-16
session reconstructed
Session detail |
Other Announcement |
CISO GLOBAL RECEIVES VALUATION OF MORE THAN $50 MILLION FOR INITIAL SUITE OF IP SOLUTIONS
08:30 ET premarket |
63.8% of the move was gone five sessions later. Month end +13.80% on 2024-02-29 |
| 45 | MIRA | +45.99% |
against the close of 2024-02-02
session reconstructed
Session detail |
Other Announcement |
MIRA Pharmaceuticals Provides Corporate Update
08:30 ET premarket |
46.2% of the move was gone five sessions later. Month end +8.06% on 2024-02-29 |
| 46 | UCAR under $25M today Also on the opposite board this month on both boards | +45.52% |
against the close of 2024-02-07
session reconstructed
Session detail |
Leadership Change |
U Power Announces Appointment of New Independent Director
05:00 ET premarket |
6.3% of the move was gone five sessions later. Month end +11.08% on 2024-02-29 |
| 47 | BLZE | +45.15% |
against the close of 2024-02-15
session reconstructed
Session detail |
Earnings |
Backblaze Announces Fourth Quarter and Full Year 2023 Financial Results
16:05 ET after hours |
51.9% of the move was gone five sessions later. Month end +30.31% on 2024-02-29 |
| 48 | MATV | +42.69% |
against the close of 2024-02-21
session reconstructed
Session detail |
Earnings |
Mativ Announces Fourth Quarter and Full Year 2023 Results
16:40 ET after hours |
Five sessions later the move was 11.7% bigger, at +47.70%. Month end +47.70% on 2024-02-29 |
| 49 | CRDL | +42.31% |
against the close of 2024-02-14
session reconstructed
Session detail |
Clinical Trial Results |
Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis
07:27 ET premarket |
Five sessions later the move was 31.8% bigger, at +55.77%. Month end +98.08% on 2024-02-29 |
| 50 | ONMD | +42.23% |
against the close of 2024-02-28
session reconstructed
Session detail |
Contract / Partnership |
OneMedNet Signs New Network Partnership Agreement with One of the Largest Private Hospital Operators in U.S.
08:00 ET premarket |
60.2% of the move was gone five sessions later. Month end +42.23% on 2024-02-29 same session This month ended before the fifth session after the move. |
| 51 | EFSH under $25M today More than one ranked move this month 2+ ranked moves | +42.05% |
against the close of 2024-02-09
session reconstructed
Session detail |
Earnings |
1847 Holdings Announces Positive Restatement of Financial Results for Subsidiary and Reduction in Loss from Operations of Approximately $3.6 Million and Increase in Assets of $642,000 for 2022
07:30 ET premarket |
15.9% of the move was gone five sessions later. Month end +42.56% on 2024-02-29 |
| 52 | BMR under $25M today More than one ranked move this month 2+ ranked moves | +41.31% |
against the close of 2024-02-12
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Beamr Imaging Ltd. Announces Pricing of $12 Million Public Offering
20:02 ET after hours |
95.4% of the move was gone five sessions later. Month end -19.30% on 2024-02-29 |
| 53 | EFSH under $25M today More than one ranked move this month 2+ ranked moves | +41.30% |
against the close of 2024-02-08
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
1847 Holdings LLC Announces Pricing of $5.0 Million Public Offering
09:20 ET premarket |
Five sessions later the move was 233.4% bigger, at +137.68%. Month end +101.45% on 2024-02-29 |
| 54 | JMIA | +41.18% |
against the close of 2024-02-14
session reconstructed
Session detail |
Earnings |
Jumia Reports Fourth Quarter and Full Year 2023 Results
08:00 ET premarket |
19.5% of the move was gone five sessions later. Month end +88.54% on 2024-02-29 |
| 55 | KRYS | +41.02% |
against the close of 2024-02-23
session reconstructed
Session detail |
Earnings |
Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
08:00 ET premarket |
Five sessions later the move was 6.5% bigger, at +43.67%. Month end +43.24% on 2024-02-29 This month ended before the fifth session after the move. |
| 56 | ACMR | +40.80% |
against the close of 2024-02-27
session reconstructed
Session detail |
Earnings |
ACM Research Reports Fourth Quarter and Fiscal Year 2023 Results
05:00 ET premarket |
2.5% of the move was gone five sessions later. Month end +41.90% on 2024-02-29 This month ended before the fifth session after the move. |
| 57 | SGMO | +40.15% |
against the close of 2024-02-09
session reconstructed
Session detail |
FDA & Regulatory |
Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease
08:05 ET premarket |
Five sessions later the move was 162.6% bigger, at +105.43%. Month end +101.95% on 2024-02-29 |
| 58 | APLT under $25M today More than one ranked move this month 2+ ranked moves | +39.93% |
against the close of 2024-02-14
session reconstructed
Session detail |
Clinical Trial Results |
Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency
07:00 ET premarket |
Five sessions later the move was 186.0% bigger, at +114.18%. Month end +165.67% on 2024-02-29 |
| 59 | TAOP under $25M today | +39.81% |
against the close of 2024-02-06
session reconstructed
Session detail |
Contract / Partnership |
Taoping Reports Record 78% Year-Over-Year Contract Revenue Growth for January
08:50 ET premarket |
Five sessions later the move was 31.7% bigger, at +52.43%. Month end +26.21% on 2024-02-29 |
| 60 | MODD | +39.44% |
against the close of 2024-02-15
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Modular Medical Announces Proposed Public Offering
16:15 ET after hours |
6.1% of the move was gone five sessions later. Month end +57.77% on 2024-02-29 |
| 61 | LASE | +39.42% |
against the close of 2024-02-28
session reconstructed
Session detail |
Other Announcement |
Laser Photonics Scores Order from Pima Air & Space Museum for Its CleanTech Laser Cleaning System
07:00 ET premarket |
Five sessions later the move was 195.2% bigger, at +116.35%. Month end +39.42% on 2024-02-29 same session This month ended before the fifth session after the move. |
| 62 | WISH | +39.11% |
against the close of 2024-02-09
session reconstructed
Session detail |
M&A / Acquisition |
ContextLogic Announces Agreement to Sell Substantially All Operating Assets and Liabilities Associated with Wish to Qoo10 for $173 Million in Cash
08:00 ET premarket |
Five sessions later the move was 36.1% bigger, at +53.22%. Month end +44.44% on 2024-02-29 |
| 63 | BRLS | +38.90% |
against the close of 2024-02-06
session reconstructed
Session detail |
Reverse Merger / Shell |
Borealis Foods Inc., a Rapidly Growing, Mission-Driven Food Tech Company, Completes Business Combination and Will Commence Trading on Nasdaq Under the Symbol "BRLS"
13:41 ET intraday |
It gave back the whole move and closed 1.11% below the pre-news price. Month end -5.55% on 2024-02-29 |
| 64 | GTHX Also on the opposite board this month on both boards | +38.75% |
against the close of 2024-02-27
session reconstructed
Session detail |
Earnings |
G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
06:30 ET premarket |
Five sessions later the move was 21.5% bigger, at +47.08%. Month end +38.33% on 2024-02-29 This month ended before the fifth session after the move. |
| 65 | VLCN | +38.68% |
against the close of 2024-02-27
session reconstructed
Session detail |
Leadership Change |
Business Update from John Kim New CEO at Volcon Inc
07:30 ET premarket |
It gave back the whole move and closed 0.28% below the pre-news price. Month end +52.44% on 2024-02-29 This month ended before the fifth session after the move. |
| 66 | DNLI | +38.25% |
against the close of 2024-02-26
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Denali Therapeutics Announces $500 million Private Placement Equity Financing
08:00 ET premarket |
44.9% of the move was gone five sessions later. Month end +17.11% on 2024-02-29 This month ended before the fifth session after the move. |
| 67 | MICS under $25M today | +38.08% |
against the close of 2024-02-26
session reconstructed
Session detail |
Other Announcement |
Company Generates Record Subscriptions Sales for 2023 Holiday Season
07:00 ET premarket |
Five sessions later the move was 46.2% bigger, at +55.68%. Month end +32.67% on 2024-02-29 This month ended before the fifth session after the move. |
| 68 | LRMR | +36.84% |
against the close of 2024-02-13
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Larimar Therapeutics Announces Proposed Underwritten Public Offering
16:18 ET after hours |
8.1% of the move was gone five sessions later. Month end +31.58% on 2024-02-29 |
| 69 | SNAL | +36.36% |
against the close of 2024-02-26
session reconstructed
Session detail |
Other Announcement |
Snail’s Innovates Development Pipeline with AI Technology
08:00 ET premarket |
50.0% of the move was gone five sessions later. Month end +21.58% on 2024-02-29 This month ended before the fifth session after the move. |
| 70 | CTMX | +36.36% |
against the close of 2024-02-26
session reconstructed
Session detail |
Other Announcement |
CytomX Therapeutics to Present at Upcoming March Investor Conferences
08:00 ET premarket |
Five sessions later the move was 78.4% bigger, at +64.85%. Month end +48.48% on 2024-02-29 This month ended before the fifth session after the move. |
| 71 | UMAC | +36.34% |
against the close of 2024-02-22
session reconstructed
Session detail |
M&A / Acquisition |
Unusual Machines Completes Acquisitions of Fat Shark and Rotor Riot
16:01 ET after hours |
80.2% of the move was gone five sessions later. Month end +16.63% on 2024-02-29 This month ended before the fifth session after the move. |
| 72 | VGAS | +36.07% |
against the close of 2024-02-12
session reconstructed
Session detail |
Contract / Partnership |
Verde Clean Fuels, Inc. and Cottonmouth Ventures LLC Announce Joint Development Agreement for a Proposed Natural Gas-to-Gasoline Facility in Permian Basin
07:30 ET premarket |
Five sessions later the move was 142.6% bigger, at +87.50%. Month end +51.79% on 2024-02-29 |
| 73 | BMR under $25M today More than one ranked move this month 2+ ranked moves | +35.70% |
against the close of 2024-02-15
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Beamr Imaging Ltd. Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares
16:15 ET after hours |
It gave back the whole move and closed 15.00% below the pre-news price. Month end -19.70% on 2024-02-29 |
| 74 | PEGA | +35.67% |
against the close of 2024-02-14
session reconstructed
Session detail |
Earnings |
Pega Delivers Double-Digit ACV Growth and Record Cash Flow in Q4 2023
16:05 ET after hours |
28.1% of the move was gone five sessions later. Month end +28.26% on 2024-02-29 |
| 75 | AHG | +35.67% |
against the close of 2024-01-31
session reconstructed
Session detail |
M&A / Acquisition |
AHG Announces Plan to Acquire Online Clinic
16:00 ET after hours |
100.0% of the move was gone five sessions later. Month end -17.07% on 2024-02-29 |
| 76 | IINN under $25M today | +35.42% |
against the close of 2024-02-13
session reconstructed
Session detail |
Other Announcement |
Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
07:30 ET premarket |
8.8% of the move was gone five sessions later. Month end +68.75% on 2024-02-29 |
| 77 | FREE | +35.33% |
against the close of 2024-02-12
session reconstructed
Session detail |
M&A / Acquisition |
Whole Earth Brands Signs Definitive Agreement to be Acquired by Affiliates of Sababa Holdings FREE, LLC
08:00 ET premarket |
Five sessions later the move was 2.4% bigger, at +36.18%. Month end +36.18% on 2024-02-29 |
| 78 | LYFT | +35.12% |
against the close of 2024-02-13
session reconstructed
Session detail |
Earnings |
Lyft Announces Fourth Quarter and Full-Year 2023 Results
16:05 ET after hours |
11.3% of the move was gone five sessions later. Month end +30.92% on 2024-02-29 |
| 79 | DOOR | +35.09% |
against the close of 2024-02-08
session reconstructed
Session detail |
M&A / Acquisition |
Owens Corning Announces $3.9 Billion Acquisition of Masonite to Strengthen Position in Building and Construction Materials
07:05 ET premarket |
2.3% of the move was gone five sessions later. Month end +34.81% on 2024-02-29 |
| 80 | LUNR | +34.54% |
against the close of 2024-02-14
session reconstructed
Session detail |
Other Announcement |
IM-1 Mission Nova-C Lunar Lander Successfully Enroute to the Moon Following its Launch on SpaceX’s Falcon 9
09:09 ET premarket |
Five sessions later the move was 168.0% bigger, at +92.57%. Month end +21.08% on 2024-02-29 |
| 81 | AREN | +34.53% |
against the close of 2024-02-14
session reconstructed
Session detail |
Other Announcement |
Manoj Bhargava Invests $12 Million More in The Arena Group
18:25 ET after hours |
25.0% of the move was gone five sessions later. Month end +38.85% on 2024-02-29 |
| 82 | ADVM Also on the opposite board this month release reads negative on both boards | +34.51% |
against the close of 2024-02-02
session reconstructed
Session detail |
Offering / Dilution Rose on dilution Release reads negative, stock rose 34.51% |
Adverum Biotechnologies Announces $127.5 Million Private Placement Financing
07:45 ET premarket |
Five sessions later the move was 16.3% bigger, at +40.14%. Month end +39.44% on 2024-02-29 |
| 83 | CFLT | +34.09% |
against the close of 2024-02-07
session reconstructed
Session detail |
Earnings |
Confluent Announces Fourth Quarter and Fiscal Year 2023 Financial Results
16:03 ET after hours |
Five sessions later the move was 13.6% bigger, at +38.74%. Month end +39.44% on 2024-02-29 |
| 84 | PYXS | +33.26% |
against the close of 2024-02-26
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Pyxis Oncology Announces $50 Million Private Placement
08:00 ET premarket |
Five sessions later the move was 5.1% bigger, at +34.94%. Month end +33.05% on 2024-02-29 This month ended before the fifth session after the move. |
| 85 | ATRA | +33.10% |
against the close of 2024-01-31
session reconstructed
Session detail |
Clinical Trial Results |
Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology
18:30 ET after hours |
2.0% of the move was gone five sessions later. Month end +24.76% on 2024-02-29 |
| 86 | PRLD | +33.05% |
against the close of 2024-02-15
session reconstructed
Session detail |
Earnings |
Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
16:05 ET after hours |
47.0% of the move was gone five sessions later. Month end +23.56% on 2024-02-29 |
| 87 | SMCI | +32.87% |
against the close of 2024-02-21
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Supermicro Announces Proposed Offering of $1.5 Billion of Convertible Senior Notes Due 2029
17:09 ET after hours |
45.3% of the move was gone five sessions later. Month end +17.97% on 2024-02-29 |
| 88 | CLSK | +32.86% |
against the close of 2024-02-08
session reconstructed
Session detail |
Earnings |
CleanSpark Reports First Quarter FY2024 Financial Results
16:00 ET after hours |
Five sessions later the move was 113.3% bigger, at +70.10%. Month end +59.24% on 2024-02-29 |
| 89 | WGS | +32.63% |
against the close of 2024-02-20
session reconstructed
Session detail |
Earnings |
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
16:26 ET after hours |
Five sessions later the move was 46.8% bigger, at +47.90%. Month end +55.53% on 2024-02-29 |
| 90 | APLT under $25M today More than one ranked move this month 2+ ranked moves | +32.62% |
against the close of 2024-02-27
session reconstructed
Session detail |
FDA & Regulatory |
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
08:00 ET premarket |
51.7% of the move was gone five sessions later. Month end +27.60% on 2024-02-29 This month ended before the fifth session after the move. |
| 91 | TELL | +32.57% |
against the close of 2024-02-05
session reconstructed
Session detail |
Other Announcement |
Tellurian Explores Sale of Haynesville Upstream Assets
07:00 ET premarket |
Five sessions later the move was 128.8% bigger, at +74.51%. Month end +120.47% on 2024-02-29 |
| 92 | BRTX under $25M today Also on the opposite board this month on both boards | +32.52% |
against the close of 2024-01-31
session reconstructed
Session detail |
Clinical Trial Results |
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
07:30 ET premarket |
It gave back the whole move and closed 21.47% below the pre-news price. Month end -14.11% on 2024-02-29 |
| 93 | WATT | +32.30% |
against the close of 2024-02-14
session reconstructed
Session detail |
Other Announcement |
WiGL and Energous Announce Developmental Milestone to Bring Touchless Wireless Power Transfer Networks to Market
09:30 ET intraday |
88.8% of the move was gone five sessions later. Month end +8.53% on 2024-02-29 |
| 94 | VERX release reads negative | +32.20% |
against the close of 2024-02-28
session reconstructed
Session detail |
Earnings Release reads negative, stock rose 32.20% |
Vertex Announces Fourth Quarter and Full Year 2023 Financial Results
07:00 ET premarket |
45.6% of the move was gone five sessions later. Month end +32.20% on 2024-02-29 same session This month ended before the fifth session after the move. |
| 95 | BLNK | +32.09% |
against the close of 2024-02-13
session reconstructed
Session detail |
Other Announcement |
BLINK CHARGING ANNOUNCES PRELIMINARY FULL-YEAR 2023 REVENUE IN EXCESS OF $140 MILLION, REITERATES ADJUSTED EBITDA PROFITABILITY TARGET
07:45 ET premarket |
73.3% of the move was gone five sessions later. Month end +18.66% on 2024-02-29 |
| 96 | CVNA | +32.09% |
against the close of 2024-02-22
session reconstructed
Session detail |
Earnings |
Carvana Announces Record Fourth Quarter and Full Year 2023 Results
16:10 ET after hours |
Five sessions later the move was 81.6% bigger, at +58.29%. Month end +44.88% on 2024-02-29 This month ended before the fifth session after the move. |
| 97 | IOVA | +31.48% |
against the close of 2024-02-16
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock
06:30 ET premarket |
Five sessions later the move was 188.9% bigger, at +90.93%. Month end +73.88% on 2024-02-29 |
| 98 | MNY | +31.43% |
against the close of 2024-02-08
session reconstructed
Session detail |
Leadership Change |
MoneyHero Group Announces Resignation of Chief Financial Officer
16:30 ET after hours |
Five sessions later the move was 59.1% bigger, at +50.00%. Month end +54.29% on 2024-02-29 |
| 99 | TENX Also on the opposite board this month on both boards | +31.31% |
against the close of 2024-02-05
session reconstructed
Session detail |
Other Announcement |
Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly Broadening IP Protection for Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
08:30 ET premarket |
It gave back the whole move and closed 49.43% below the pre-news price. Month end -47.36% on 2024-02-29 |
| 100 | AHCO | +31.06% |
against the close of 2024-02-26
session reconstructed
Session detail |
Earnings |
AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook
07:00 ET premarket |
Five sessions later the move was 15.6% bigger, at +35.91%. Month end +34.08% on 2024-02-29 This month ended before the fifth session after the move. |
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 268 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band
4 candidate events for this board could not be anchored to a trading session and are not listed.
1 event was left out of this board because the stored move and the session's own closing prices disagree by far more than a measurement difference, so neither figure could be published.
3 events were left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.
1 event was left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.
1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.
Company names are not shown on months older than a year, because only the current holder of each ticker is known.
Whole board, unfiltered
In February 2024, the median gainer had given back 8.5% of its move five sessions later; the largest catalyst group was Other Announcement, 28 of the 100 events, at a median of +54.3%.
Close-to-close change on the measured trading session, against the previous close.
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.
Which catalysts drove the board
Swipe the table sideways for the day +5 columns.
| Catalyst | Events | Share of board | Median move close to close | Median at day +5 | Still above the pre-news close at day +5 |
|---|---|---|---|---|---|
| Other Announcement | 28 | 28.0% | +54.3% | +57.4% | 92.9% of 28 |
| Earnings | 24 | 24.0% | +41.1% | +47.4% | 100.0% of 24 |
| Offering / Dilution | 14 | 14.0% | +38.8% | +36.0% | 92.9% of 14 |
| Clinical Trial Results | 12 | 12.0% | +86.5% | +57.5% | 91.7% of 12 |
| M&A / Acquisition | 8 | 8.0% | Fewer than 10 events in this group, so no figures are shown. | ||
6 other catalyst types, 14 events: Contract / Partnership, Leadership Change, FDA & Regulatory, Reverse Merger / Shell, Uplisting / Compliance, Crypto & Treasury.
How much of the move survived
| Horizon | Still above the pre-news close close to close | Median change since the measured close as a share of the move |
|---|---|---|
| Day +1 | 99.0% of 100 | 0.2% given back, of 100 |
| Day +5 | 92.0% of 100 | 8.5% given back, of 100 |
| Month end | 92.6% of 95 | 15.4% given back, of 95 |
| Month end falls before day +5 for 22 of these 95 events, so this row is not a later horizon than the one above it. 95 of the 100 events have a month-end close later than the measured session; 5 have it on the measured session itself. | ||
Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.
Repeat runners
Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.
Moved twice or more inside February 2024
Two or more ranked moves this month, each on a different trading day.
| Symbol | Measured sessions | Best move |
|---|---|---|
| BMR | 3Other Announcement, Offering / Dilution | +371.56% |
| INBS | 2Earnings | +146.89% |
| MNPR | 2Clinical Trial Results | +96.49% |
| EFSH | 2Earnings, Offering / Dilution | +42.05% |
| APLT | 2Clinical Trial Results, FDA & Regulatory | +39.93% |
Also risen on news in earlier months
Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.
| Symbol | Months | Best move |
|---|---|---|
| GETR | 2024-01, 2023-12 | +84.85% |
| SIDU | 2024-01, 2023-12 | +163.16% |
| DATS | 2024-01, 2023-12 | +58.25% |
| CYN | 2024-01, 2023-12 | +64.00% |
| SHOT | 2024-01, 2023-11 | +34.91% |
| GNS | 2024-01, 2023-12 | +28.77% |
| SNES | 2024-01, 2023-12 | +34.38% |
| AXGN | 2024-01, 2023-11 | +36.90% |
| CDIO | 2024-01, 2023-11 | +123.23% |
| SLDB | 2023-12, 2023-11 | +68.42% |
| PAPL | 2023-12, 2023-11 | +50.68% |
| INBSthis month too | 2023-12, 2023-11 | +92.51% |
What the board was made of
Price before the move
Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.
When the announcement landed
Volume against normal
3 events have too little trading history for a relative volume, and are not in the tiers above.
Industry
31 other industries, 35 events
Industry not known: 18.0%
3 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.
Against January 2024
100 events in the comparable window.
January 2024 median +31.1%, selected from the 8,863 events in that month's eligible pool
February 2024 median +42.1%, 11.0 points above January 2024. February 2024's median is taken over the 100 ranked rows, selected from the 10,433 events in that month's eligible pool.
How this ranking is measured
Close-to-close change on the measured trading session, against the previous close.
- An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
- One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
- A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
- No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.
Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.
Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.
Market cap is not shown on months older than a year, because only today's figure exists.
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.
On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.
This archive starts at 2020-04, the first month with ranked moves.